nusinersen (ISIS 396443)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for nusinersen (ISIS 396443), covering 2017-07-28 to 2017-07-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy [Phase 3]